Unlock your academic potential and expand your network by joining us!

Philippe Spiess

Dr. Philippe Spiess

Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research ...

Share Link

Share

Information

Philippe E. Spiess is a genitourinary oncologist and the assistant chief of surgical services at the Moffitt Cancer Center. He is a full professor of oncology and urology at the University of South Florida Morsani College of Medicine. Before joining Moffitt, Hhe completed a three-year SUO-accredited urologic oncology fellowship at the MD Anderson Cancer Center in Houston, Texas. His research interests include novel therapies for advanced renal, bladder, and penile cancers. He currently serves as the vice-chair of the NCCN panel on bladder and penile cancers and sits on several international editorial boards, including Urologic Oncology: Seminars and Original Investigations, BMC Urology, the British Journal of Medicine and Medical Research, and the International Brazilian Journal of Urology. He has delivered major lectures and seminars at national and international oncology meetings and has been appointed to serve on the American Urological Association Core Curriculum. A native of Canada, he obtained a master’s in experimental urology surgery at McGill University in Montreal and a medical degree from the University of Toronto. He completed a urology residency at McGill University. He is a fellow of the Royal College of Physicians and Surgeons in Canada and a member of the Société Internationale d’Urologie.

Research Keywords & Expertise

Penile cancer
Renal cell cancer
HPV-related cancers

Fingerprints

35%
Penile cancer
5%
Renal cell cancer
5%
HPV-related cancers

Short Biography

Philippe E. Spiess is a genitourinary oncologist and the assistant chief of surgical services at the Moffitt Cancer Center. He is a full professor of oncology and urology at the University of South Florida Morsani College of Medicine. Before joining Moffitt, Hhe completed a three-year SUO-accredited urologic oncology fellowship at the MD Anderson Cancer Center in Houston, Texas. His research interests include novel therapies for advanced renal, bladder, and penile cancers. He currently serves as the vice-chair of the NCCN panel on bladder and penile cancers and sits on several international editorial boards, including Urologic Oncology: Seminars and Original Investigations, BMC Urology, the British Journal of Medicine and Medical Research, and the International Brazilian Journal of Urology. He has delivered major lectures and seminars at national and international oncology meetings and has been appointed to serve on the American Urological Association Core Curriculum. A native of Canada, he obtained a master’s in experimental urology surgery at McGill University in Montreal and a medical degree from the University of Toronto. He completed a urology residency at McGill University. He is a fellow of the Royal College of Physicians and Surgeons in Canada and a member of the Société Internationale d’Urologie.